This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.
Audiences:
Health Professionals
International Agencies
Policy Makers
Focus Area:
TB
Subjects:
MDR TB
Treatment- TB Disease
TB Treatment
Treatment- Medication Information
Extensively Drug-Resistant TB (XCR TB)
Publication Date:
2013
Format:
Report
Last Updated Date:
Publication ID:
33881